Table 1 Clinical parameters and the reference group in SCAD patients (median (min-max)
MPO < 200 ng/ml, n = 26 | MPO = 200–300 ng/ml n = 26 | MPO > 300 ng/ml n = 15 | MPO ng/ml n = 67 | Controls n = 15 | |
|---|---|---|---|---|---|
Ages (years) | 61 (58–67 | 66 (56–70) | 63 (58–68) | 63 (56–70) | 55 (27–55) |
Gender (male/ female) | 14 F, 12 M | 15F, 11 M | 9F, 6 M | 38F, 29 M | 10F, 5 M |
BMI (kg/m2) | 28.4 (25–30) | 27.6 (24.5–29.4) | 28.1 (25.1–34.9) | 28.0 (24.5–34.9) | 25 (22–27) |
eGFR (ml/min/1.73 m2) | 95.1 (84.4–103.6) | 83 (63–94.6) | 79 (69–109) | 90 (63–109) | 125 (95–160) |
Creatinine (μmol/L) | 87 (77–94) | 80 (64–92) | 87 (65–97) | 80 (72–97) | 97 (71–108) |
Hypertension | n = 9 | n = 10 | n = 12 | 31 | – |
Diabetes mellitus | – | 4 | 8 | 12 | – |